See more : Gujarat Investa Limited (GUJINV.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Landec Corporation (LNDC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Landec Corporation, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Yadea Group Holdings Ltd. (1585.HK) Income Statement Analysis – Financial Results
- Epuja Spiritech Ltd. (SAGARPROD.BO) Income Statement Analysis – Financial Results
- China Botanic Pharmaceutical Inc. (CBPI) Income Statement Analysis – Financial Results
- SpringWorks Therapeutics, Inc. (SWTX) Income Statement Analysis – Financial Results
- Jilin University Zhengyuan Information Technologies Co., Ltd. (003029.SZ) Income Statement Analysis – Financial Results
Landec Corporation (LNDC)
About Landec Corporation
Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. Landec Corporation was incorporated in 1986 and is headquartered in Santa Maria, California.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 185.79M | 544.16M | 590.37M | 557.56M | 524.23M | 532.26M | 541.10M | 539.26M | 476.81M | 441.71M | 317.55M | 276.73M | 238.22M | 235.94M | 238.53M | 210.50M | 231.95M | 205.23M | 192.09M | 0.00 | 190.88M | 209.55M | 35.40M | 33.50M | 9.50M | 2.50M |
| Cost of Revenue | 135.42M | 462.69M | 515.38M | 476.56M | 445.89M | 449.07M | 470.14M | 473.85M | 414.25M | 378.95M | 265.41M | 230.03M | 204.46M | 201.66M | 200.30M | 178.11M | 191.91M | 173.26M | 162.30M | 0.00 | 163.30M | 170.12M | 19.30M | 18.20M | 5.10M | 500.00K |
| Gross Profit | 50.37M | 81.47M | 74.99M | 81.00M | 78.34M | 83.19M | 70.96M | 65.41M | 62.56M | 62.76M | 52.14M | 46.70M | 33.77M | 34.28M | 38.23M | 32.39M | 40.04M | 31.97M | 29.79M | 0.00 | 27.59M | 39.43M | 16.10M | 15.30M | 4.40M | 2.00M |
| Gross Profit Ratio | 27.11% | 14.97% | 12.70% | 14.53% | 14.94% | 15.63% | 13.11% | 12.13% | 13.12% | 14.21% | 16.42% | 16.87% | 14.17% | 14.53% | 16.03% | 15.39% | 17.26% | 15.58% | 15.51% | 0.00% | 14.45% | 18.82% | 45.48% | 45.67% | 46.32% | 80.00% |
| Research & Development | 7.84M | 10.22M | 11.10M | 11.47M | 12.80M | 9.47M | 7.23M | 6.99M | 7.20M | 9.29M | 9.63M | 9.28M | 4.36M | 3.67M | 3.25M | 3.07M | 3.04M | 2.54M | 3.73M | 0.00 | 3.27M | 4.70M | 5.80M | 5.70M | 7.60M | 3.80M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 46.13M | 65.36M | 72.19M | 64.06M | 51.95M | 55.63M | 49.52M | 39.96M | 35.17M | 32.53M | 26.52M | 24.61M | 17.70M | 18.02M | 19.80M | 21.62M | 27.98M | 23.41M | 22.00M | 0.00 | 26.97M | 28.88M | 11.20M | 10.80M | 4.70M | 3.30M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.93M | 1.42M | 4.78M | 0.00 | 0.00 | 0.00 | -22.67M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.07M | 2.20M | 2.10M | 1.10M | 500.00K |
| Operating Expenses | 53.97M | 75.59M | 83.29M | 75.53M | 64.75M | 65.10M | 56.74M | 46.95M | 42.37M | 37.89M | 37.56M | 38.66M | 22.06M | 21.68M | 23.05M | 2.02M | 31.02M | 25.96M | 25.74M | 0.00 | 30.24M | 39.64M | 19.20M | 18.60M | 13.40M | 7.60M |
| Cost & Expenses | 189.38M | 538.27M | 598.67M | 552.08M | 510.64M | 514.17M | 526.89M | 520.80M | 456.62M | 416.84M | 302.98M | 268.70M | 226.52M | 223.34M | 223.35M | 180.13M | 222.93M | 199.21M | 188.04M | 0.00 | 193.53M | 209.76M | 38.50M | 36.80M | 18.50M | 8.10M |
| Interest Income | 81.00K | 48.00K | 103.00K | 145.00K | 211.00K | 16.00K | 71.00K | 315.00K | 260.00K | 179.00K | 180.00K | 430.00K | 834.00K | 1.31M | 2.22M | 1.95M | 633.00K | 214.00K | 247.00K | 0.00 | 617.00K | 617.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 17.36M | 15.34M | 9.60M | 5.23M | 1.95M | 1.83M | 1.99M | 1.83M | 1.65M | 2.01M | 929.00K | 820.00K | 88.00K | 8.00K | -22.00K | -251.00K | -452.00K | -414.00K | -1.55M | 0.00 | -2.79M | -2.79M | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 17.88M | 19.87M | 18.84M | 15.23M | 12.41M | 10.68M | 9.40M | 7.09M | 7.11M | 7.30M | 5.62M | 5.31M | 3.36M | 3.14M | 3.20M | 3.26M | 3.20M | 3.47M | 3.71M | 0.00 | 5.43M | 6.07M | 2.20M | 2.10M | 1.10M | 500.00K |
| EBITDA | -46.28M | -13.50M | -22.87M | 22.39M | 29.83M | 27.43M | -7.66M | 18.46M | 20.19M | 24.87M | 14.58M | 14.23M | 11.70M | 16.49M | 15.18M | 34.91M | 9.02M | 6.02M | 4.06M | 0.00 | -13.36M | 2.03M | -500.00K | -600.00K | -7.50M | -3.70M |
| EBITDA Ratio | -36.62% | -0.97% | -3.87% | 4.02% | 5.69% | 5.15% | -1.42% | 5.60% | 8.07% | 9.36% | 8.32% | 5.14% | 4.91% | 6.99% | 8.43% | 16.58% | 5.11% | 4.32% | 3.44% | 0.00% | -7.00% | 0.97% | -1.41% | -1.79% | -78.95% | -148.00% |
| Operating Income | -85.91M | -25.12M | -41.70M | 7.16M | 11.85M | 16.28M | -17.06M | 16.95M | 18.80M | 23.04M | 13.83M | 7.64M | 12.45M | 13.35M | 15.18M | 30.37M | 9.02M | 6.02M | 2.90M | 0.00 | -18.79M | -4.04M | -2.70M | -2.70M | -8.60M | -4.20M |
| Operating Income Ratio | -46.24% | -4.62% | -7.06% | 1.28% | 2.26% | 3.06% | -3.15% | 3.14% | 3.94% | 5.22% | 4.35% | 2.76% | 5.23% | 5.66% | 6.36% | 14.43% | 3.89% | 2.93% | 1.51% | 0.00% | -9.84% | -1.93% | -7.63% | -8.06% | -90.53% | -168.00% |
| Total Other Income/Expenses | -5.84M | -15.34M | -9.60M | -3.52M | 4.55M | -1.26M | -1.79M | 4.52M | 11.13M | 7.40M | 6.46M | 410.00K | -3.73M | -8.00K | 1.72M | 1.28M | -396.00K | -619.00K | 0.00 | 0.00 | 13.95M | 521.00K | 0.00 | 0.00 | 1.70M | 1.50M |
| Income Before Tax | -52.12M | -40.47M | -51.31M | 3.64M | 16.40M | 15.01M | -18.85M | 21.47M | 29.93M | 32.26M | 20.28M | 8.44M | 8.73M | 13.34M | 16.90M | 31.65M | 8.63M | 5.40M | 2.93M | 0.00 | -4.84M | -2.13M | -2.70M | -2.70M | -6.90M | -2.70M |
| Income Before Tax Ratio | -28.05% | -7.44% | -8.69% | 0.65% | 3.13% | 2.82% | -3.48% | 3.98% | 6.28% | 7.30% | 6.39% | 3.05% | 3.66% | 5.65% | 7.08% | 15.03% | 3.72% | 2.63% | 1.52% | 0.00% | -2.53% | -1.01% | -7.63% | -8.06% | -72.63% | -108.00% |
| Income Tax Expense | -5.84M | -7.80M | -13.12M | 1.52M | -9.36M | 4.34M | -7.40M | 7.75M | 10.58M | 9.45M | 7.19M | 4.18M | 4.26M | 5.61M | 3.35M | 2.46M | -24.00K | -4.00K | 29.00K | 0.00 | 3.04M | -42.00K | 100.00K | 200.00K | 1.70M | 1.50M |
| Net Income | -46.28M | -32.67M | -38.19M | 2.12M | 25.76M | 10.68M | -11.45M | 13.73M | 19.34M | 22.81M | 13.10M | 4.26M | 4.47M | 7.73M | 13.54M | 29.19M | 8.65M | 5.40M | 2.90M | 0.00 | -18.79M | -2.08M | -2.80M | -2.90M | -8.60M | -4.20M |
| Net Income Ratio | -24.91% | -6.00% | -6.47% | 0.38% | 4.91% | 2.01% | -2.12% | 2.55% | 4.06% | 5.16% | 4.12% | 1.54% | 1.87% | 3.28% | 5.68% | 13.87% | 3.73% | 2.63% | 1.51% | 0.00% | -9.84% | -0.99% | -7.91% | -8.66% | -90.53% | -168.00% |
| EPS | -1.57 | -1.11 | -1.31 | 0.07 | 0.92 | 0.39 | -0.42 | 0.51 | 0.72 | 0.86 | 0.51 | 0.16 | 0.17 | 0.30 | 0.52 | 1.16 | 0.35 | 0.23 | 0.14 | 0.00 | -1.15 | -0.13 | -0.21 | -0.23 | -0.77 | -0.55 |
| EPS Diluted | -1.57 | -1.11 | -1.31 | 0.07 | 0.92 | 0.39 | -0.42 | 0.50 | 0.71 | 0.86 | 0.50 | 0.16 | 0.17 | 0.29 | 0.50 | 1.10 | 0.34 | 0.22 | 0.12 | 0.00 | -1.15 | -0.13 | -0.21 | -0.22 | -0.77 | -0.55 |
| Weighted Avg Shares Out | 29.47M | 29.33M | 29.22M | 29.10M | 27.92M | 27.50M | 27.15M | 26.99M | 26.82M | 26.40M | 25.64M | 26.41M | 26.36M | 26.18M | 26.07M | 25.26M | 24.55M | 23.71M | 21.40M | 21.11M | 16.37M | 15.80M | 13.27M | 12.77M | 11.14M | 7.70M |
| Weighted Avg Shares Out (Dil) | 29.47M | 29.33M | 29.22M | 29.10M | 27.92M | 27.65M | 27.15M | 27.34M | 27.12M | 26.63M | 26.13M | 26.63M | 26.63M | 26.75M | 26.94M | 26.56M | 25.66M | 24.61M | 23.56M | 22.86M | 16.37M | 15.80M | 13.27M | 13.33M | 11.14M | 7.70M |
Landec Enters into Transportation Management, Warehousing, and Transportation Services Agreement with Castellini Company LLC
A continuation of Project SWIFT, Agreement seeks to improve Curation Foods' market reach while further simplifying operations, including facility rationalization A continuation of Project SWIFT, Agreement seeks to improve Curation Foods' market reach while further simplifying operations, including facility rationalization
Landec (LNDC) Surges 7.1%: Is This an Indication of Further Gains?
Landec (LNDC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Landec Corporation's (LNDC) CEO Dr. Albert Bolles on Q3 2021 Results - Earnings Call Transcript
Landec Corporation's (LNDC) CEO Dr. Albert Bolles on Q3 2021 Results - Earnings Call Transcript
Landec (LNDC) Reports Q3 Loss, Lags Revenue Estimates
Landec (LNDC) delivered earnings and revenue surprises of -550.00% and -1.41%, respectively, for the quarter ended February 2021. Do the numbers hold clues to what lies ahead for the stock?
Landec: Q3 Earnings Insights
Shares of Landec (NASDAQ:LNDC) fell after the company reported Q3 results. Quarterly Results Earnings per share fell 325.00% over the past year to ($0.09), which missed the estimate of $0.02.
Landec Corporation Reports Third Quarter and First Nine Months Fiscal 2021 Results
SANTA MARIA, Calif., April 07, 2021 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Lifecore Biomedical, Inc. and Curation Foods, Inc., reported results for the fiscal 2021 third quarter and year-to-date...
A Preview Of Landec's Earnings
Landec (NASDAQ:LNDC) announces its next round of earnings this Wednesday, April 07. Here is Benzinga's everything-that-matters guide for this Wednesday's Q3 earnings announcement.
Analysts Estimate Landec (LNDC) to Report a Decline in Earnings: What to Look Out for
Landec (LNDC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Landec Corporation Sets Third Quarter 2021 Earnings Conference Call for April 7, 2021 at 2 p.m. PT
SANTA MARIA, Calif., March 23, 2021 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Lifecore Biomedical, Inc. and Curation Foods, Inc., will hold a conference call on Wednesday, April 7, 2021...
Earnings Preview: Landec (LNDC) Q3 Earnings Expected to Decline
Landec (LNDC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Source: https://incomestatements.info
Category: Stock Reports